[1]
2024. Use of immunomodulatory therapies in post-surgical patients in intensive care: Benefits and risks. Research, Society and Development. 13, 8 (Aug. 2024), e3813846549. DOI:https://doi.org/10.33448/rsd-v13i8.46549.